12 February 2025

Polpharma Receives Grants for Research Projects

Polpharma has been awarded grants for the implementation of two innovative research projects as part of a competition organized by the Medical Research Agency (ABM). This competition aimed to support the development of new pharmaceutical forms of medicinal products and generic drugs.
LinkedIn Twitter Facebook Messenger Skopiuj link

Among the awarded projects by Polpharma are:

  1. Development and advancement of inhaled complex generic drugs for the treatment of respiratory diseases such as COPD and asthma – this project aims to create modern medications that will improve the quality of life for patients with respiratory diseases.
  2. Development and advancement of an injectable generic drug based on an active substance from the polypeptide group for the treatment of type 2 diabetes – this project focuses on developing modern therapies for patients with type 2 diabetes.

These prestigious grants are evidence of Polpharma’s commitment to the development of innovative pharmaceutical solutions aimed at improving patients’ quality of life.

Polpharma on its websites and mobile applications (“Website”) uses cookies and other related technologies (“cookies”). Self-management of cookies is possible by changing the settings in your web browser. If you do not agree to the collection of personal data through cookies, you can change the settings in your web browser or leave the Website.

By using the Website without changing the settings in your web browser, you accept Polpharma’s use of cookies. By accepting the settings in your web browser, you agree to profiling based on the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect the lawfulness of the processing that was carried out on the basis of consent before its withdrawal.

More information can be found in the Cookies Policy.